Evidence indicates that the amplification of genes in DM may result in a dynamic regulation of gene expression and resistance to EGFR TKIs for EGFRvIII‐positive glioblastomas (Nathanson et al., 2014). The gene discussed is EGFR; the disease is glioblastoma.